Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin D in MS: A vitamin for 4 seasons.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Anesthetic management of a parturient with neuromyelitis optica.
Can a Low-Cost Webcam be Used for a Remote Neurological Exam?
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
Freedom from disease activity in multiple sclerosis.
Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Teriflunomide (AUBAGIO). Multiple sclerosis: just a metabolite of leflunomide.
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
[Marihuana and cannobinoids as medicaments].
Natalizumab adverse events are rare in patients with multiple sclerosis.
Immunomodulation of fucosyl-lactose and lacto-N-fucopentaose on mononuclear cells from multiple sclerosis and healthy subjects.
The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Aging, widowhood, multiple sclerosis, and a dog.
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
[Emerging therapies for multiple sclerosis.]
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Motivational interviewing may improve exercise experience for people with multiple sclerosis: A small randomized trial.
MR Imaging in Multiple Sclerosis: The Accuracy of 3D Double Inversion Recovery at 3 Tesla and the Potential for Single Sequence Imaging.
Does multiple sclerosis affect glucose tolerance?
Pages
« first
‹ previous
…
186
187
188
189
190
191
192
193
194
…
next ›
last »